News Cradle Genomics raises $17m for prenatal genetic testing R&D Prenatal testing firm Cradle Genomics has raised $17 million in an early funding round led by the investment arm of the genetic testing firm Illumina.
News Is Lilly about to swoop on Verve Therapeutics? Ahead of an opt-in decision on a PCSK9 inhibitor candidate, Eli Lilly is reported to be in advanced takeover negotiations with Verve Therapeutics.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face